Pricing

Iovance Biotherapeutics

355 people · 0 jobs

‌

Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.

Industries

Headquarters

San Carlos, United States

Employees

Links

Org chart

Frederick G. Vogt

Interim CEO, President & General Counsel

Collapse

COO

Howard B. Johnson

Chief Business Officer

SVP, Head of Digital & Information Technology

EVP, Human Resources

EVP, Quality

SVP, Research

Stefanie Bulilan

Sr. Director Quality Systems And Compliance

Kerry Elizabeth Wilson Esq.

Executive Counsel

Executive Counsel

Chief Commercial Officer (cco)

Sara Pellegrino

Svp, Investor Relations & Corporate Communications

Senior Patent Counsel

Associate General Counsel

Matthew Rosinack

Senior Vice President Finance

Michele Fernandes

SVP Portfolio Management

Executive Medical Director

Senior Securities And Corporate Counsel

Board & advisors

Chairman

Director

Director

Director

Athena Countouriotis

Director

Director

Teams

Leadership Team

23 people · 0 jobs

Clinical Operations and Research

10 people · 0 jobs

Quality Assurance and Compliance

13 people · 0 jobs

Information Technology and Data Management

11 people · 0 jobs

Finance and Accounting

8 people · 0 jobs

Human Resources and Talent Acquisition

6 people · 0 jobs

Offices

HQ
34 people · 0 jobs
MA
+30

Similar companies

Editas Medicine

5 followers

Arcus Biosciences

3 followers

Gilead Sciences

163 followers

Regeneron

135 followers

Illumina

79 followers

Agilent Technologies

85 followers

Verily Life Sciences

46 followers

Alexion Pharmaceuticals

45 followers

GRAIL

30 followers

Cytiva

19 followers

CRISPR Therapeutics

13 followers

Explore companies